CD19 is occasionally expressed on leukemic cells in patients with AML, e.g., in a subset of patients with core-binding factor leukemias and t(8;21)(q22;q22) (AML1/ETO [RUNX1/RUNX1T1]) translocations. Here, CD19 is linked to leukemia.